Literature DB >> 7806909

Genetic determinants of mortality in acute necrotizing pancreatitis.

H Rinderknecht1.   

Abstract

Acute necrotizing pancreatitis (ANP), which often progresses to infection, sepsis, and multisystem organ failure, runs a course remarkably similar to that seen frequently after severe burns, massive physical trauma, or major surgery. There is extensive evidence that the development of the sepsis response is mediated by immunocytes, particularly activated polymorphonuclear leukocytes (PMNLs) and their secretions (reactive oxygen species, lysosomal hydrolases, cytokines, and so on). Some years ago it was suggested that the high mortality of ANP may be related to an overaggressive immunological defense system of the host rather than to autodigestion of the gland. Recent investigations of the immunoregulatory responses following surgery or other trauma have not only furnished additional support for this concept, but also revealed some genetic factors that may critically influence the outcome of posttraumatic illness including ANP. The prognostic significance of abnormal, early polymorphonuclear leukocyte (PMNL) activation in the development of sepsis, high neutrophil expression of certain receptor molecules, low monocyte and lymphocyte expression of major histocompatibility antigen MHC-class II, and the influence of the genetically encoded TNF and IL-1 secretion on the course of the illness are discussed and related to ANP. Evidence is presented for the potential usefulness of some of these parameters in the prognosis and future treatment of ANP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806909     DOI: 10.1007/bf02925604

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  24 in total

1.  Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells.

Authors:  D G Okrent; A K Lichtenstein; T Ganz
Journal:  Am Rev Respir Dis       Date:  1990-01

2.  Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient.

Authors:  M J Hershman; W G Cheadle; S R Wellhausen; P F Davidson; H C Polk
Journal:  Br J Surg       Date:  1990-02       Impact factor: 6.939

3.  Trauma and the immune response.

Authors:  D R Green; E Faist
Journal:  Immunol Today       Date:  1988-09

Review 4.  Activation of pancreatic zymogens. Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation.

Authors:  H Rinderknecht
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

5.  Polymorphonuclear leukocyte activation. An early marker of the postsurgical sepsis response.

Authors:  C H Wakefield; P D Carey; S Foulds; J R Monson; P J Guillou
Journal:  Arch Surg       Date:  1993-04

6.  The surgical intensive care unit: current concepts in infection.

Authors:  J L Meakins; B Wicklund; R A Forse; A P McLean
Journal:  Surg Clin North Am       Date:  1980-02       Impact factor: 2.741

7.  Prevention of increased pulmonary vascular permeability after pancreatitis by granulocyte depletion in sheep.

Authors:  P S Barie; M V Tahamont; A B Malik
Journal:  Am Rev Respir Dis       Date:  1982-11

8.  A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.

Authors:  P Pederzoli; C Bassi; S Vesentini; A Campedelli
Journal:  Surg Gynecol Obstet       Date:  1993-05

9.  Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.

Authors:  P Pederzoli; G Cavallini; M Falconi; C Bassi
Journal:  Int J Pancreatol       Date:  1993-10

10.  Relationship between the functional status of the reticuloendothelial system and the outcome of experimentally induced pancreatitis in young mice.

Authors:  N F Adham; M K Song; G C Haberfelde
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

View more
  6 in total

1.  Cytokine gene expression in peripheral blood mononuclear cells reflects a systemic immune response in alcoholic chronic pancreatitis.

Authors:  C Hanck; S Rossol; A Hartmann; M V Singer
Journal:  Int J Pancreatol       Date:  1999-12

2.  CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications.

Authors:  Bettina Rau; Katja Baumgart; Colin M Krüger; Martin Schilling; Hans G Beger
Journal:  Intensive Care Med       Date:  2003-02-15       Impact factor: 17.440

3.  Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers.

Authors:  B Rau; A Bauer; A Wang; F Gansauge; H Weidenbach; T Nevalainen; B Poch; H G Beger; A K Nussler
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

Review 4.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

5.  The selective inhibition of type IV phosphodiesterase attenuates the severity of the acute pancreatitis in rats.

Authors:  Hakan Mersin; Fikret İrkin; Ugur Berberoglu; Kaptan Gülben; Hakan Özdemir; Önder Öngürü
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

6.  Comparative effects of several therapatic agents on hepatic damage induced by acute experimental pancreatitis.

Authors:  Mukaddes Eşrefoğlu; Mehmet Gül; Fahri Turan
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.